Inaktiver Wert

Andere Sprachen GOLD SWAP OTC Bulletin Board

Aktien

GDSW

US38074W1009

GDSW

Schlusskurs OTC Bulletin Board Andere Börsenplätze
- ^USD	-

15:08	Silo Pharma nähert sich optimaler Formulierung für Ketamin-Implantat	MT
05.06.	Top Absteiger am Mittag	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Silo Pharma Close to Achieving Optimal Formulation for Ketamine Implant	15:08
Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia	14:18
Top Midday Decliners	05.06.
Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules	05.06.
Sector Update: Health Care Stocks Rise Tuesday Afternoon	04.06.
Silo Pharma Submits Pre-Investigational NDA For PTSD, Anxiety Treatment; Shares Rise	04.06.
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety	04.06.
Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety	04.06.
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04.06.
Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention	21.05.
Silo Pharma, Inc. Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention	21.05.
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine	14.05.
Silo Pharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	13.05.
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment	23.04.
Silo Pharma, Inc. Announces Positive Results for Intranasal PTSD Treatment	23.04.
Silo Pharma Says It Exercised Option to License Alzheimer's Therapeutic From Columbia University	10.04.
Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic	10.04.
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.	05.04.
Silo Pharma, Inc.'s Equity Buyback Plan Extended till March 31, 2024.	04.04.
Tranche Update on Silo Pharma, Inc.'s Equity Buyback Plan announced on January 31, 2023.	25.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen GOLD SWAP OTC Bulletin Board

Aktien

GDSW

US38074W1009

GDSW

Andere Sprachen

Filter